Uterocervical Angle in Idiopathic Polyhydramnios
Sponsor
Nefise Nazlı YENIGUL (Other)
Overall Status
Completed
CT.gov ID
NCT03828695
Collaborator
(none)
60
1
1
5.9
10.1
Study Details
Study Description
Brief Summary
To evaluate the performance of uterocervical angle (UCA) in the prediction of preterm labor in isolated polyhydramnios
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Study Type:
Interventional
Actual Enrollment
:
60 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Screening
Official Title:
Efficacy and Efficiency of Uterocervical Angle for Prediction of Preterm Labor in Patients With Idiopathic Polyhydramnios: a Prospective Cohort Study
Actual Study Start Date
:
Jan 1, 2019
Actual Primary Completion Date
:
Jun 30, 2019
Actual Study Completion Date
:
Jun 30, 2019
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Other: uterocervical angle uterocervical angle is the angle between lower segment of uterus and cervix |
Other: uterocervical angle
uterocervical angle is the angle between lower segment of uterus and cervix
|
Outcome Measures
Primary Outcome Measures
- prediction of preterm birth by uterocervical angle in patients with idiopathic polyhydramnios. [6 month]
During the study period, women were enrolled and uterocervical angle were measured in the first evaluations of polyhydramnios patients in policlinics. Routine pregnancy follow-up was done by our team and weeks of delivery and maternal-fetal outcomes were noted.
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
to 45 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
-
isolated polyhydramnios pregnancies
-
no previous systemic illnesses
Exclusion Criteria:
-
abnormal Pap smear
-
previous cesarean section
-
history of dilatation and curettage (D&C)
-
history of loop electrosurgical excision procedure (LEEP) and cervical conization
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Nefise N YENIGUL | Sanlıurfa | Turkey |
Sponsors and Collaborators
- Nefise Nazlı YENIGUL
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Nefise Nazlı YENIGUL,
Ph.D. Assistant Professor Department of Obstetrics and Gynecology,
Sanliurfa Mehmet Akif Inan Education and Research Hospital
ClinicalTrials.gov Identifier:
NCT03828695
Other Study ID Numbers:
- 10988
First Posted:
Feb 4, 2019
Last Update Posted:
Jul 23, 2019
Last Verified:
Jul 1, 2019
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms: